CrushSCI.com
116.8平均天数
107中位天数
41最短天数
237最长天数
5272025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

71 天

Hypoxia‐inducible factor 2α inhibition in renal cell carcinoma: From von Hippel–Lindau biology to targeted therapeutics

作者
Yu‐Wei Chen; Fumika Sano; Rana R. McKay展开收起
作者单位
1. Division of Medical Oncology University of California, San Diego Moores Cancer Center San Diego California USA; 2. University of California, San Diego School of Medicine San Diego California USA展开收起
PDF源文件 DOI 网页
111 天

Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies

作者
Cuipeng Qiu; Claus Høgdall; Hailing Yang; Wei‐Lei Yang; Tim S. Poulsen; Karen S. Anderson; Zhen Lu; Robert C. Bast; Estrid Høgdall展开收起
作者单位
1. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Department of Gynecology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark; 3. Molecular Unit Department of Pathology Herlev Hospital University of Copenhagen Herlev Denmark; 4. Biodesign Institute Arizona State University Tempe Arizona USA展开收起
PDF源文件 DOI 网页
225 天

Integration of individual‐level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer

作者
Wonyoung Jung; Gary Hettinger; Vivek Narayan; Lin Mei; Samuel Takvorian; Yehoda M. Martei; Amy Clark; Anran Huang; Kellie Mcdermott; Amanda M. Smith; Congying Xia; Kyunga Ko; Javier Sierra Pagan; Daniel Koropeckyj‐Cox; Kelly Getz; Carmen E. Guerra; Oluwadamilola M. Fayanju; Sanchit Kumar; Kirsten M. M. Beyer; Tiffany Powell‐Wiley; Clyde Yancy; Yong‐Moon Mark Park; Bonnie Ky展开收起
作者单位
1. Division of Cardiology Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 2. Thalheimer Center for Cardio‐Oncology Abramson Cancer Center Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 3. Department of Population Health New York University Grossman School of Medicine New York New York USA; 4. Division of Hematology and Oncology Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 5. Department of Internal Medicine Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 6. Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 7. Division of General Internal Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 8. Department of Surgery Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 9. Institute for Health and Humanity Medical College of Wisconsin Milwaukee Wisconsin USA; 10. Social Determinants of Obesity and Cardiovascular Risk Laboratory Cardiovascular Branch Division of Intramural Research National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA; 11. Intramural Research Program National Institute on Minority Health and Health Disparities National Institutes of Health Bethesda Maryland USA; 12. Department of Internal Medicine Division of Cardiology Feinberg School of Medicine Northwestern University Chicago Illinois USA; 13. Department of Epidemiology Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock Arkansas USA; 14. Cancer Prevention and Population Sciences Research Program Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA展开收起
PDF源文件 DOI 网页
56 天

Biomarker use in the prostate cancer screening pathway: Maps of the evidence

作者
Rita L. Shiau; Jessica C. Griffin; Clarissa A. B. Troutman; Rose Relevo; Karli K. Kondo展开收起
作者单位
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USA展开收起
PDF源文件 DOI 网页
87 天

Prostate‐specific antigen‐based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline

作者
Jessica C. Griffin; Rita L. Shiau; Clarissa A. B. Troutman; Alanna Welsh; Emily Edwards; Ibironke A. Ajayi; Rose Relevo; Karli K. Kondo展开收起
作者单位
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USA展开收起
PDF源文件 DOI 网页
127 天

Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients

作者
Monica Sarker; Zhengyi Deng; Eric C. Kauffman; Li Tang; Marilyn L. Kwan; Marvin E. Langston; Sumati Gupta; G. Daniel Grass; Eric A. Singer; Yousef Zakharia; Paul V. Viscuse; Laura Graham; Saum Ghodoussipour; Bodour Salhia; Sean Q. Kern; Adanma Ayanambakkam; Zin Myint; Jennifer King; Seyi Oderinde; Michelle L. Churchman; Robert J. Rounbehler; Ken Batai展开收起
作者单位
1. Department of Cancer Prevention and Control Roswell Park Comprehensive Cancer Center Buffalo New York USA; 2. Department of Urology Stanford University School of Medicine Stanford California USA; 3. Department of Epidemiology Stanford University Palo Alto California USA; 4. Department of Urology Roswell Park Comprehensive Cancer Center Buffalo New York USA; 5. Division of Research Kaiser Permanente Northern California Pleasanton California USA; 6. Huntsman Cancer Institute Salt Lake City Utah USA; 7. H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA; 8. Department of Urology Ohio State University Columbus Ohio USA; 9. University of Iowa Holden Comprehensive Cancer Center Iowa City Iowa USA; 10. Division of Hematology/Oncology University of Virginia Comprehensive Cancer Center Charlottesville Virginia USA; 11. University of Colorado Anschutz Medical Campus Aurora Colorado USA; 12. Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA; 13. Norris Comprehensive Cancer Center and Keck School of Medicine of the University of Southern California Los Angeles California USA; 14. Murtha Cancer Center Uniformed Services University of the Health Sciences Bethesda Maryland USA; 15. Stephenson Cancer Center University of Oklahoma Oklahoma City Oklahoma USA; 16. Markey Cancer Center University of Kentucky Lexington Kentucky USA; 17. Indiana University Simon Comprehensive Cancer Center Indianapolis Indiana USA; 18. Aster Insights Tampa Florida USA展开收起
PDF源文件 DOI 网页

FAQ

CANCER审稿要多久?

截至2026-11-17,CrushSCI 收录了 CANCER 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 41 天(GPRC5D‐targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies,2026-06-16 收稿,2026-07-27 录用),最慢一篇用了 237 天;平均 116.8 天,中位数 107 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。